Compare TRVI & PLGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRVI | PLGO |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | United States | Bermuda |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2019 | 2015 |
| Metric | TRVI | PLGO |
|---|---|---|
| Price | $13.31 | $28.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 9 |
| Target Price | ★ $28.18 | $26.94 |
| AVG Volume (30 Days) | ★ 1.5M | 374.2K |
| Earning Date | 11-09-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 3.06% |
| EPS Growth | ★ 31.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $5.49 |
| Revenue Next Year | N/A | $5.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.82 | $20.85 |
| 52 Week High | $20.22 | $29.70 |
| Indicator | TRVI | PLGO |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 67.91 |
| Support Level | $13.00 | $23.95 |
| Resistance Level | $13.55 | N/A |
| Average True Range (ATR) | 0.88 | 0.76 |
| MACD | 0.06 | 0.15 |
| Stochastic Oscillator | 20.92 | 71.02 |
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
Pelagos Insurance Capital Ltd operates in the specialty insurance and reinsurance sector. Its activities include capital allocation, risk selection, and the deployment of capital through underwriting partnerships across insurance and reinsurance markets. The company manages a diversified portfolio and works with underwriting partners to provide insurance and reinsurance solutions to clients and brokers.